News and breakthroughs in tissue analysis, biomarkers, and pathology technology.
Flagship Receives Global Technology Innovation Award
Frost & Sullivan News Release: Flagship Biosciences Recognized by Frost & Sullivan for Its Industry-leading AI-powered cTA® Platform for Predictive Diagnostics Santa Clara, CA, September
Flagship’s Digital Tissue Image Analysis Approach Validated in Assessment of Dystrophin Muscle Biopsies; Findings Published in Archives of Pathology & Laboratory Medicine
Westminster, CO, September 6, 2018 – Flagship Biosciences’ MuscleMap algorithm that supports therapeutic development for DMD, a fatal neuromuscular disease, has been validated to be
Flagship Secures Series A Funding to Accelerate Growth in Drug Development and Diagnostics Services
Westminster, CO, July 10, 2018 – Flagship Biosciences has closed a series A round of funding to advance the growth of its computational tissue image
Flagship publishes article on using IHC and digital imaging to improve patient selection for PD-L1 therapy
First NSCLC study using cTA to report IHC data in immuno-oncology Westminster, CO, June 7, 2018 – Flagship is proud to co-author the research paper,
Flagship Participates in ASCO Annual Meeting 2018
Download Flagship ASCO booth map Westminster, CO, May 23, 2018 – Flagship Biosciences will participate in the largest annual gathering of oncology professionals and researchers
Flagship to Present Computational Tissue Analysis Solutions for Advancing Drug Development at AACR Annual Meeting
Download Flagship AACR reference Westminster, CO, April 12, 2018 – Flagship Biosciences’ cTA® and decision support platform will be featured in four scientific poster presentations
